Long-Acting Anti-HIV Agents

ViImmune is developing a new generation of long-acting anti-HIV agents designed to provide sustained antiviral activity and reduce the frequency of dosing. These agents utilize a dual-action mechanism to target multiple stages of the HIV life cycle, minimizing the risk of resistance.